YOUR GENOMIC ANALYSIS PROCESS SeqOne provides you with an integrated system that manages your genomics analysis process from raw data to final results.
SeqOne is designed from the ground up to improve your efficiency and accuracy in analysing genomic information at scale. Our platform automates many tasks that today cost you time and introduce the risk of errors. You will find that you can perform more analyses and obtain more detailed insights from every analysis.
SeqOne is open. We believe that the open-source community is the best way to provide cutting-edge bioinformatic pipelines with proven performance and robust, reliable behavior. Our platform incorporates pipelines that have been benchmarked to ensure optimal performance.
Fast responsive filtering to find causal variants
An easy-to-use, visual environment
Choose your analysis at the click of the mouse
View in-depth quality reports
SeqOne's platform includes bioinformatic applications optimised to provide medically actionable results in the following areas
SeqOne’s mission: to make genomic medicine accessible to everyone
Next Generation Sequencing (NGS) has made obtaining detailed genomic information more affordable than ever. Yet today, the challenge is to find ways to cost-effectively analyse all this raw genomic data while ensuring quality of the results. SeqOne’s mission is to provide advanced genomic analysis tools that make it possible to analyse NGS data cost-effectively at scale and hence to ensure that the benefits of genomic medicine are available to everyone.
Are you a guru in bioinformatics, molecular biology, machine learning or high-performance big data infrastructure? Do you want to change the way in which the healthcare industry meets its challenges?
SeqOne is an open platform that lets users easily access and use the best genomics analysis software without needing advanced computer skills. If you have developed an open-source bioinformatic pipeline and are looking for a way to reach a larger user base, SeqOne can help.
The SeqOne bioinformatic developer programme provides the support and resources to help you make your pipeline easier to use and accessible to many more potential users.
EUROFINS BIOMNIS AND SEQONE PARTNER TO IMPROVE CLINICAL ACCESS TO WHOLE EXOME TESTING
Eighty percent of rare diseases are genetic in origin and result from a small number of genetic mutations. Identifying these variations is essential in diagnosing the diseases and can dramatically improve patient care. Making Whole Exome sequencing more affordable to improve diagnostic efficiency Since 2017, Eurofins Biomnis has offered “Whole Exome” sequencing which, starting from […]Read more See all